AI assistant
Sending…
vTv Therapeutics Inc. — Director's Dealing 2021
Oct 21, 2021
34596_dirs_2021-10-21_dc8bffcd-a170-4fd4-986e-b4ebe6208e38.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: vTv Therapeutics Inc. (VTVT)
CIK: 0001641489
Period of Report: 2021-10-19
Reporting Person: Prasad Deepa (Director, President and CEO)
More from vTv Therapeutics Inc.
Share Issue/Capital Change
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Investor Presentation
2026
Feb 26
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Regulatory Filings
2026
Feb 2
Board/Management Information
2025
Dec 19
Major Shareholding Notification
2025
Dec 9